Fred Freund - Dec 14, 2022 Form 3 Insider Report for BrightView Holdings, Inc. (BV)

Signature
Jonathan M. Gottsegen, Power of Attorney
Stock symbol
BV
Transactions as of
Dec 14, 2022
Transactions value $
$0
Form type
3
Date filed
12/16/2022, 03:00 PM
Next filing
May 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BV Common Stock 14.4K Dec 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BV Stock Options (Right to Buy) Dec 14, 2022 Common Stock 9.3K $22.00 Direct F2
holding BV Stock Options (Right to Buy) Dec 14, 2022 Common Stock 6K $13.49 Direct F3
holding BV Stock Options (Right to Buy) Dec 14, 2022 Common Stock 4K $16.86 Direct F4
holding BV Stock Options (Right to Buy) Dec 14, 2022 Common Stock 8.35K $16.89 Direct F5
holding BV Stock Options (Right to Buy) Dec 14, 2022 Common Stock 10.5K $13.78 Direct F6
holding BV Stock Options (Right to Buy) Dec 14, 2022 Common Stock 17.8K $15.04 Direct F7
holding BV Restricted Stock Units Dec 14, 2022 Common Stock 500 Direct F8, F9
holding BV Restricted Stock Units Dec 14, 2022 Common Stock 900 Direct F9, F10
holding BV Restricted Stock Units Dec 14, 2022 Common Stock 2.69K Direct F9, F11
holding BV Restricted Stock Units Dec 14, 2022 Common Stock 4.5K Direct F9, F12
holding BV Restricted Stock Units Dec 14, 2022 Common Stock 6.08K Direct F9, F13
holding BV Restricted Stock Units Dec 14, 2022 Common Stock 88.6K Direct F9, F14
holding BV Restricted Stock Units Dec 14, 2022 Common Stock 3.34K Direct F9, F15
holding BV Restricted Stock Units Dec 14, 2022 Common Stock 26.7K Direct F9, F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock acquired under the Issuer's employee stock purchase plan and unvested shares of restricted stock. Does not include unvested performance shares which will be reported upon achievement of certain performance criteria.
F2 Consists of 8,577 time and performance-based options that are full vested and exercisable and 727 time-based options that will vest on December 12, 2022.
F3 Represents grant of time-based options which are fully vested.
F4 Represents a grant of time-based options of which 75% are vested. The remaining 25% will vest on June 3, 2023.
F5 Represents grant of time-based options of which 75% are vested. The remaining 25% will vest on November 22, 2023.
F6 Represents a grant of time-based options of which 50% are vested. The remaining 50% will vest in two equal annual installments beginning on November 19, 2023.
F7 Represents a grant of time-based options of which 25% are vested. The remaining 75% will vest in three equal annual installments beginning on November 18, 2023.
F8 Represents grant of time-based restricted stock units that vest on June 3, 2023.
F9 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units will be settled in either common stock or cash (or a combination thereof).
F10 Represents grant of time-based restricted stock units that vest on November 22, 2023.
F11 Represents grant of time-based restricted stock units that vest in two equal annual installments beginning on November 19, 2023.
F12 Represents grant of time-based restricted stock units that vest in three equal annual installments beginning on May 19, 2023.
F13 Represents grant of time-based restricted stock units that vest in three equal annual installments beginning on November 18, 2023.
F14 Represents grant of time-based restricted stock units that vest on September 29, 2025.
F15 Represents grant of time-based restricted stock units that vest on November 18, 2023.
F16 Represents grant of time-based restricted stock units that vest in four equal annual installments beginning on November 18, 2023.

Remarks:

Exhibit 24: Power of Attorney